RESULTS
In the study, 19 patients submitted to LVIHR were compared with 18 patients submitted
to RVIHR.No significant difference was noted in costs related to hospital stay (RVIHR:
1,641.50±767.85; LVIHR: 1,749.61±1,130.48; p=0.738), inhaled medical gases (ICU)
(RVIHR: 0.00; LVIHR: 10.83±44.92; p=0.331), inhaled medical gases (ward) (RVIHR:
0.00; LVIHR: 10.79±44.75; p=0.331), human resources (ICU) (RVIHR: 0.00; LVIHR:
104.60±433.68; p=0.331), human resources (ward) (RVIHR: 1,320.43±632.22; LVIHR:
1,443.11±948.26; p=0.648), diagnostic tests (RVIHR: 48.69±80.10; LVIHR 82.81±157.66;
p 0.421), and prosthesis, meshes, and special devices (RVIHR: 1,790.98±2,023.45;
LVIHR: 1,674.82±594.17; p=0.810). Meantime, the amount spent on operation room time
(RVIHR: 2,447.91±644.79; LVIHR: 1,989.67±763.00; p=0.030), inhaled medical gases
(OR) (RVIHR: 270.57±211.51; LVIHR: 84.55±252.34; p